Compare Enovix Corporation (ENVX) vs Select Medical Holdings Corporation (SEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enovix Corporation vs Select Medical Holdings Corporation — how do they compare? Enovix Corporation trades at $4.63 (market cap $1.11B), while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: Select Medical Holdings Corporation is the larger of the two by market cap, and Select Medical Holdings Corporation pays a 1.51% dividend while Enovix Corporation pays none. Which is the better fit depends on your goals.
| ENVX | SEM | |
|---|---|---|
Market Cap | $1.11B | $2.05B |
Sector | Technology | Health |
52-Week High | $15.93 | $16.66 |
52-Week Low | $4.84 | $11.77 |
Enterprise Value | $1.13B | $5.01B |
Dividend Yield | — | 1.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $4.855, down 4.05% today amid bearish technical signals. The company shows strong revenue growth potential with recent earnings beats but operates at a significant loss, reflected in a -499.64% net margin. Positive sentiment is driven by analyst consensus with a $12.75 price target and recent operational hires from Apple, though cash flow remains negative as production scales.
Outlook hinges on successful manufacturing ramp-up and smartphone battery qualification. High execution risk and cash burn present challenges, but leadership in silicon-anode technology offers long-term upside if commercial targets are met. Investors face volatility but potential reward from current discounted levels.
Select Medical Holdings Corporation (SEM) trades at $16.51, unchanged on the day, with a mixed technical picture showing bullish oscillators but bearish moving averages. Recent earnings show volatility with Q3 2025 beating estimates but Q1 2026 missing, while valuation ratios like P/E of 15.43 and P/S of 0.36 suggest moderate pricing. The company announced a $0.06 dividend for H1 2026, but news highlights its acquisition completion by a consortium led by Robert A. Ortenzio in June 2026, with legal investigations into the fairness of the $16.50 per share deal.
The outlook is clouded by acquisition-related uncertainties and legal scrutiny, posing risks to shareholder value. Analyst consensus leans neutral with 57.15% hold ratings, reflecting cautious sentiment amid the takeover. Investors should weigh the stable fundamentals against potential dilution or litigation outcomes, with the stock's near-term direction tied to resolution of these corporate actions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →About Select Medical Holdings Corporation
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →
